Morgan Stanley Stock Performance
Morgan Stanley shares traded at $202.52, reflecting a challenging near-term trajectory with declines of 5.44% over the past month and 9.23% over the trailing three months, per SID market data. Despite this recent weakness, the stock maintained a positive 13.55% return over the prior twelve months. From a technical standpoint, MS traded below its 50-day moving average of $214.33 but remained above its 200-day moving average of $191.55, suggesting the pullback occurred within a broader uptrend. The 14-day relative strength index registered at 30.5, placing the stock near oversold territory according to conventional technical thresholds. Morgan Stanley carried a beta of 1.215, indicating higher sensitivity to broad market movements compared to the benchmark index. Average daily trading volume stood at approximately 5.7 million shares, per Massive/Polygon data, reflecting consistent institutional liquidity in the name.
Morgan Stanley Valuation Analysis
Morgan Stanley's valuation metrics position the firm within established ranges for large-cap financial services companies. The stock traded at a price-to-earnings ratio of 17.50, according to SID market data, while the PEG ratio stood at 1.70, suggesting the market prices in moderate earnings growth relative to the current multiple. The price-to-book ratio registered at 2.57, reflecting a premium to tangible equity that aligns with the firm's wealth management and investment banking franchise value. Morgan Stanley's market capitalization totaled approximately $286.3 billion, per SEC filings and market data. The company offered a dividend yield of 2.14%, providing a steady income component for shareholders. Within the financial services sector, these metrics reflect Morgan Stanley's positioning as a diversified institution balancing capital markets revenue with fee-based wealth management income streams that typically command higher valuation premiums.
Smart Money Activity for MS
Morgan Stanley's composite smart money score registered at 42 out of 100, reflecting a neutral overall signal according to SID market data. Institutional positioning scored a perfect 25 out of 25, indicating robust ownership and continued accumulation by major fund managers per 13F institutional filings. However, insider activity presented a contrasting picture, scoring 0 out of 25. SEC Form 4 filings revealed seven insider transactions over the past 90 days, all of which were sales with zero purchases recorded during the period. This selling pattern, while not uncommon among executives at large financial institutions managing compensation-related equity, contributed to the subdued insider score. Dark pool activity scored 5.5 out of 25, suggesting limited notable off-exchange accumulation. Congressional trading activity scored 12 out of 25, indicating moderate legislative interest in the stock. The divergence between strong institutional conviction and persistent insider selling creates a mixed directional signal for investors monitoring smart money flows.
Morgan Stanley Earnings Outlook
Morgan Stanley has demonstrated a consistent pattern of exceeding analyst expectations in its most recent reported quarters. In the July 2026 quarter, the company posted earnings of $3.46 per share against a consensus estimate of $2.81, delivering a positive surprise of $0.65, according to company earnings reports. The April 2026 quarter similarly outperformed, with actual earnings of $3.43 per share surpassing the $3.04 estimate by $0.39. Looking ahead, analysts project earnings of $2.95 per share for the upcoming reporting period and $3.14 per share for the following quarter, per consensus analyst estimates. The sequential earnings trajectory reflects resilience across Morgan Stanley's diversified business segments. The magnitude of recent beats — averaging approximately $0.52 above estimates across the two reported quarters — suggests that analyst models may continue to underestimate the firm's revenue generation capacity, particularly in wealth management and institutional securities divisions.
Wall Street Analyst Ratings for MS
Wall Street coverage of Morgan Stanley reflects a generally constructive stance, with recent ratings skewing toward buy-side recommendations. UBS reiterated a Buy rating on August 3, 2026, maintaining its positive outlook on the stock, per Wall Street analyst reports. Evercore ISI Group reaffirmed an Outperform rating on July 17, 2026, while Freedom Broker upgraded the stock to Buy from Hold on the same date, representing the most notable rating change in the recent cycle. On the more cautious side, HSBC maintained a Hold rating on July 21, 2026, and Citigroup reiterated its Neutral position on July 17, 2026. According to SID consensus data, the distribution of ratings shows three firms with Buy or equivalent recommendations against two maintaining neutral stances, with no active Sell ratings among the most recent coverage updates. This consensus backdrop suggests moderate analyst confidence despite the stock's recent pullback toward oversold technical levels and its retreat below the 50-day moving average.
